
FLNA
Healthcare · Biotechnology · $21.4M market cap
$0.4251-0.02 (-5.1%)Nov 13, 4:00 PM EST
Next report
Before the open
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +3.8% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 11, 2027 · upcoming | Before the open | -0.26 | — | — |
| Nov 5, 2026 | Before the open | -0.24 | -0.22 | +8.3% |
| Jul 29, 2026 | Before the open | -0.22 | -0.18 | +18.2% |
| May 7, 2026 | Before the open | -0.23 | -0.21 | +8.7% |
| Mar 12, 2026 | Time not confirmed | -0.30 | -0.26 | +13.3% |
| Nov 12, 2025 | Before the open | -0.27 | -0.22 | +18.5% |
| Aug 14, 2025 | Time not confirmed | — | -0.92 | — |
| May 8, 2025 | Time not confirmed | — | -0.48 | — |
| Mar 3, 2025 | Before the open | -0.68 | -0.57 | +16.2% |
| Nov 7, 2024 | Before the open | -0.88 | -0.58 | +34.1% |
| Aug 8, 2024 | Before the open | -0.40 | -1.28 | -220.0% |
| May 13, 2024 | Time not confirmed | — | -0.43 | — |
| Feb 28, 2024 | Before the open | -0.40 | -0.50 |
Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of…
| -25.0% |
| Nov 7, 2023 | Before the open | -0.90 | -0.61 | +32.2% |
| Aug 3, 2023 | Before the open | -0.58 | -0.63 | -8.6% |
| May 1, 2023 | Before the open | -0.56 | -0.58 | -3.6% |
| Feb 28, 2023 | Time not confirmed | — | -0.47 | — |
| Nov 7, 2022 | Before the open | -0.51 | -0.51 | 0.0% |
| Aug 4, 2022 | After the close | -0.49 | -0.48 | +2.0% |
| May 5, 2022 | Before the open | -0.43 | -0.44 | -2.3% |
| Mar 1, 2022 | Time not confirmed | — | -0.35 | — |
| Nov 10, 2021 | Before the open | -0.16 | -0.24 | -50.0% |
| Aug 3, 2021 | Before the open | -0.13 | -0.13 | 0.0% |
| Apr 21, 2021 | Before the open | -0.08 | -0.09 | -12.5% |
| Mar 23, 2021 | Time not confirmed | — | -0.09 | — |
| Nov 9, 2020 | Before the open | -0.07 | -0.06 | +14.3% |
| Aug 12, 2020 | After the close | -0.06 | -0.05 | +16.7% |
| May 6, 2020 | Time not confirmed | — | -0.05 | — |
| Mar 26, 2020 | After the close | -0.14 | -0.09 | +35.7% |
| Oct 29, 2019 | Before the open | -0.16 | -0.04 | +75.0% |
| Aug 12, 2019 | Before the open | -0.12 | -0.06 | +50.0% |
| Apr 29, 2019 | Time not confirmed | — | -0.08 | — |
| Mar 25, 2019 | Time not confirmed | — | -0.04 | — |
| Oct 30, 2018 | Time not confirmed | — | -0.11 | — |
| Jul 26, 2018 | Time not confirmed | — | -0.36 | — |
| May 9, 2018 | Time not confirmed | — | -0.33 | — |
| Feb 5, 2018 | Time not confirmed | — | -0.37 | — |